| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |